Nitric oxide dependent metabolic and genetic dysregulation in metastatic triple-negative breast cancer
Jennifer N. Daw, Pricila K. Moly, Su Chung, Sarah Young, Nhi Van, Sara Centuori, David G. Besselsen, Nathan Ellis, Ronald L. Heimark, William R. Montfort · 2026
Read Nitric oxide dependent metabolic and genetic dysregulation in metastatic triple-negative breast cancer by Jennifer N. Daw, Pricila K. Moly, Su Chung, Sarah Young, Nhi Van, Sara Centuori, David G. Besselsen, Nathan Ellis, Ronald L. Heimark, William R. Montfort (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13659492.txt.
Description
Jennifer N Daw and co-authors studied how a gas made by inflamed tumors helps breast cancer spread, in a 2026 study. Triple-negative breast cancer is a hard-to-treat form, and spread to other organs causes most cancer deaths. Inflamed tumors switch on an enzyme, NOS2, that makes nitric oxide. The team removed that gene in a mouse tumor model.
Tumors without the gene almost stopped spreading to the lungs, while normal tumors spread widely. In cell tests, the gas pushed cells to burn sugar, scrambled their RNA marks, and woke a partner enzyme. Gene reads showed broad shifts in cell-cycle control. The work names this gas path as a drug target.
Catalog record
| CREATOR | Jennifer N. Daw, Pricila K. Moly, Su Chung, Sarah Young, Nhi Van, Sara Centuori, David G. Besselsen, Nathan Ellis, Ronald L. Heimark, William R. Montfort |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 72 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |